Howard C. Herrmann, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Wells Fargo(MODEST), Medtronic(SIGNIFICANT), Edwards Lifesciences(MODEST) OFFICER, DIRECTOR ETC: Holistick(SIGNIFICANT) OWNERSHIP/PARTNERSHIP/PRINCIPAL: Micro-Interventional Devices, Inc.(SIGNIFICANT) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Abbott Vascular(SIGNIFICANT), Ancora(SIGNIFICANT), Boston Scientific Corporation(SIGNIFICANT), Cardiovascular Research Foundation(SIGNIFICANT), WL Gore(SIGNIFICANT), Shockwave(SIGNIFICANT), University of Laval(MODEST), Edwards LifeSciences, Inc.(SIGNIFICANT), Medtronic(SIGNIFICANT) OTHER FINANCIAL BENEFIT: Mass Medical Society(SIGNIFICANT)

View Full Disclosure